Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States

BACKGROUND: Two million individuals with chronic hepatitis B (CHB) in the United States are at risk for premature death due to liver cancer and cirrhosis. CHB can be prevented by vaccination and controlled with treatment. METHODS: We created a lifetime Markov model to estimate the cost-effectiveness...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Forum Infect Dis
Autori principali: Chahal, Harinder S, Peters, Marion G, Harris, Aaron M, McCabe, Devon, Volberding, Paul, Kahn, James G
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Major Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6346293/
https://ncbi.nlm.nih.gov/pubmed/30931346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy353
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi